-+ 0.00%
-+ 0.00%
-+ 0.00%

Praxis Precision Medicines Converts EMBRAVE3 Trial to Single-Arm Study for Elsunersen in SCN2A-DEE

Reuters·12/09/2025 21:01:10

Please log in to view news